# Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy

> **NCT00832572** · PHASE4 · TERMINATED · sponsor: **Gilead Sciences** · enrollment: 5 (actual)

## Conditions studied

- Coronary Artery Disease
- Pain
- Peripheral Nervous System Diseases
- Polyneuropathy

## Interventions

- **DRUG:** Ranolazine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00832572
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2014-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832572, "Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00832572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*